Antonella Castagna Selected Research

fostemsavir

1/2022	Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy.
1/2020	Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonella Castagna Research Topics

Disease

30	Infections 12/2022 - 01/2011
21	COVID-19 06/2022 - 01/2020
20	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 12/2004
15	HIV Infections (HIV Infection) 01/2021 - 09/2003
11	Viremia 01/2022 - 06/2008
9	Neoplasms (Cancer) 03/2022 - 01/2012
9	Coinfection 02/2021 - 10/2005
6	Pneumonia (Pneumonitis) 02/2022 - 01/2014
5	Hypertension (High Blood Pressure) 01/2022 - 05/2016
5	Inflammation (Inflammations) 06/2021 - 01/2018
5	Disease Progression 06/2021 - 08/2007
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 08/2013
4	Respiratory Insufficiency (Respiratory Failure) 02/2022 - 01/2021
4	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2017
4	Syphilis 10/2021 - 01/2014
3	Insulin Resistance 11/2021 - 04/2007
3	Persistent Infection 12/2019 - 05/2013
3	Type 2 Diabetes Mellitus (MODY) 01/2017 - 08/2012
3	Diabetes Mellitus 01/2017 - 09/2003
2	Shock 02/2022 - 06/2021
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 01/2021
2	Mycoses (Diseases, Fungus) 01/2020 - 01/2018
2	Hyperbilirubinemia 12/2018 - 01/2018
2	Hepatitis B 01/2017 - 01/2014
2	Fibrosis (Cirrhosis) 01/2016 - 08/2013
2	Osteoporosis 11/2015 - 04/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2014 - 06/2012
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2022
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022

Drug/Important Bio-Agent (IBA)

22	RNA (Ribonucleic Acid)IBA 12/2022 - 04/2007
11	Pharmaceutical PreparationsIBA 01/2022 - 01/2005
7	IntegrasesIBA 03/2022 - 02/2011
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
6	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 01/2010
6	Biomarkers (Surrogate Marker)IBA 06/2021 - 07/2011
6	Emtricitabine (Emtriva)FDA Link 01/2021 - 07/2014
6	HDL CholesterolIBA 12/2018 - 04/2007
5	Interleukin-6 (Interleukin 6)IBA 04/2021 - 01/2018
4	dolutegravirIBA 11/2021 - 11/2013
4	Raltegravir Potassium FDA Link 11/2021 - 11/2013
4	Oxygen (Dioxygen)IBA 11/2021 - 11/2020
4	tenofovir alafenamideIBA 11/2021 - 11/2015
4	CobicistatIBA 01/2021 - 01/2017
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2018 - 10/2014
4	Triglycerides (Triacylglycerol)IBA 12/2018 - 04/2007
4	Atazanavir Sulfate (Reyataz)FDA Link 12/2018 - 11/2007
4	Tenofovir (Viread)FDA Link 01/2017 - 11/2015
4	Glucose (Dextrose)FDA LinkGeneric 09/2014 - 04/2007
3	Enfuvirtide (Fuzeon)FDA Link 03/2022 - 06/2008
3	Reverse Transcriptase InhibitorsIBA 01/2022 - 01/2021
3	C-Reactive ProteinIBA 01/2022 - 04/2021
3	NucleosidesIBA 01/2022 - 01/2014
3	remdesivirIBA 07/2021 - 01/2020
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2017
3	AntibodiesIBA 04/2020 - 01/2017
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2019 - 01/2010
3	LDL CholesterolIBA 12/2018 - 04/2007
3	Lamivudine (Epivir)FDA Link 01/2018 - 01/2011
3	abacavir (Ziagen)FDA Link 01/2017 - 10/2011
2	Integrase InhibitorsIBA 03/2022 - 01/2022
2	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2021
2	VaccinesIBA 01/2022 - 01/2017
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2022 - 10/2015
2	Testosterone (Sustanon)FDA Link 01/2022 - 01/2021
2	fostemsavirIBA 01/2022 - 01/2020
2	Ribavirin (Virazole)FDA LinkGeneric 12/2021 - 10/2014
2	Interleukin-1 (Interleukin 1)IBA 04/2021 - 01/2021
2	Maraviroc FDA Link 02/2021 - 05/2014
2	Monoclonal AntibodiesIBA 01/2021 - 01/2020
2	tocilizumab (atlizumab)FDA Link 01/2021 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2020
2	SteroidsIBA 01/2021 - 11/2015
2	BilirubinIBA 12/2018 - 04/2018
2	emtricitabine tenofovir alafenamideIBA 07/2018 - 01/2018
2	Darunavir (Prezista)FDA Link 07/2018 - 01/2017
2	Ritonavir (Norvir)FDA Link 01/2018 - 11/2007
2	Rilpivirine (TMC-278)IBA 11/2017 - 01/2017
2	AntigensIBA 06/2017 - 01/2017
2	elvitegravirIBA 01/2017 - 01/2017
2	Stavudine (Zerit)FDA LinkGeneric 01/2017 - 09/2003
2	CreatinineIBA 11/2015 - 01/2015
2	HDL LipoproteinsIBA 01/2015 - 09/2014
2	RacivirIBA 07/2014 - 01/2014
2	CholesterolIBA 08/2012 - 04/2007
2	Lopinavir FDA Link 11/2007 - 10/2005
1	ibalizumabIBA 03/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022

Therapy/Procedure

31	Therapeutics 01/2022 - 06/2008
11	Highly Active Antiretroviral Therapy (HAART) 06/2021 - 12/2004
7	Art Therapy 01/2022 - 07/2011
2	Hematopoietic Stem Cell Transplantation 08/2020 - 01/2020
1	Length of Stay 06/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 04/2022
1	Duration of Therapy 04/2022
1	Continuous Positive Airway Pressure 04/2022
1	Injections 03/2022